Conference abstract
Conference abstractPublished 14 Nov 2016
Do we apply current guidelines while prescribing statin therapy?
Awali Hospital, Bahrain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Introduction: Statin is the most controversial molecule , at the same time very commonly used as well as misused amongst all cardiovascukar drugs. Method : We studied a large cohort of patients to see if statin was being prescribed by specialist and general physicians simply based on their random clinical decision or current standard guidelines were being followed. Analysis and Results: It was discovered that a vast majority of patients were being prescribed Statin simply based on the numerical value of total cholesterol and LDL levels. A cardiovascular risk approach was not applied in these patients. On the other hand patients particularly diabetic who are now considered at higher risk for cardiovascular event were being missed out on statin. Appropriate potency and adequate dosing of statin therapy was not always adhered to. Statin therapy was also discontinued in patients despite strong clinical indication simply based on mild rise in liver or muscle enzymes. Use of Ezetemibe as adjunct therapy was very limited. Conclusion: Standard guidelines are not always being used while prescribing Statin treatment. Physicians still tend to initiate and stop statin thyerapy only based on their own random clinical judgement. This action does leave some high risk patients unprotected and made deprived of important and readily available drug therapy.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 13 Sep 2017
“Reappraise the Association of Dyslipidemia and CVD Risk in T2DM: How to Optimize Statin Therapy from the International Guideline Perspective”
Article · 2013
Continuous Quality Improvement: Adherence to Performance Measures - Implementation of Antiplatelet, Statin, Beta-Blocker and Angiotensin System Blockade Therapy Post Myocardial Infarction, Compliance with ACC/AHA Guidelines
Review article · 30 Jun 2018
Preventive effects of statin therapy in coronary artery diseases: Current controversy
Conference abstract · 28 Sep 2018
Assessment of prescribing statins in patients with metabolic syndrome without established coronary heart disease in khartoum
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Syed Raza”
